Murli Krishna Pharma: Revolutionizing Pharmaceutical Standards in India
With a client base of over 200, including more than 64 leading international companies, and a turnover exceeding US$ 6 million, Murli Krishna Pharma Pvt. Ltd. is making significant impact in the pharmaceutical industry in India, while setting new benchmarks and redefining standards. Murli Krishna Pharma’s performance speaks of its capabilities, with a cumulative growth of over 60% in the last three years.
As a young and dynamic drug delivery systems (DDS) company in India, MKPPL provides a range of effective solutions to optimize the delivery of pharmaceutical preparations. Established in 2004 by Dr. Satya Vadlamani and Dr. Vijay K. Shastri, the company is driven by the vision to provide the best possible range of international quality products at competitive prices through integration, research, innovation, technology, and development.
With a strong focus on innovation, quality, and customer-centric approach, Murli Krishna Pharma is revolutionizing the way pharmaceutical companies operate in the country, India.
Manufacturer of High Quality Pre-Finished Formulation Intermediates (PFI)
Murli Krishna Pharma Pvt. Ltd. excels in offering a diverse range of Pre-Finished Formulation Intermediates (PFI) and finished dosage forms that adhere to the highest quality standards. The company’s PFI product range includes pellets and micro pellets designed for various formulations like capsules, injectables, tablets, and suspensions. These products come in different percentages, mesh sizes, and release types, catering to a wide array of medical needs.
Some of the exceptional products and formulations by Murli Krishna Pharma include Aprepitant Pellets, Azithromycin MUPS & Granules, Brinzolamide Ophthalmic Nano Suspension, Budesonide SR Pellets & Nano Particles, and many more. With a focus on research and development, Murli Krishna Pharma’s products stand out for their effectiveness and reliability, making a significant impact on the healthcare landscape in India.
Innovation in Anemia Treatment
One area where Murli Krishna Pharma is making a significant impact is in the treatment of anemia and contributing to government’s ‘Anemia Mukt Bharat’. Anemia is a common condition in India, affecting a large number of people, especially women and children. Murli Krishna Pharma has developed ‘Transdermal Lotion’, a cutting-edge formulations and medications specifically targeted at addressing the various forms of anemia prevalent in the country.
This patient-friendly ‘Transdermal Lotion’ provides an easy and effective way to deliver iron supplements through the skin, addressing the shortcomings of traditional oral treatment.
By leveraging advanced technologies and scientific expertise, the company has been able to create formulations that are tailored to the specific needs of patients suffering from anemia, ensuring better outcomes and improved quality of life.
Commitment to Quality and Compliance
Murli Krishna Pharma’s commitment to quality and compliance is unparalleled which received approval by European Union, WHO, GCC and Jordanian FDA. The company adheres to the highest standards of manufacturing practices, ensuring that all its products meet stringent quality control measures. By investing in state-of-the-art facilities and employing a team of experienced professionals, Murli Krishna Pharma guarantees the safety, efficacy, and reliability of its pharmaceuticals.
Moreover, the company places a strong emphasis on regulatory compliance, following all guidelines and regulations set forth by the authorities. This dedication to quality and compliance not only ensures the integrity of Murli Krishna Pharma’s products but also instills trust and confidence among healthcare professionals and patients alike.
Customer-Centric Approach and Ethical Practices
At the core of Murli Krishna Pharma’s success is its customer-centric approach and ethical practices. The company places a high value on customer satisfaction, striving to meet the diverse needs and preferences of its clientele. By engaging with healthcare providers, patients, and other stakeholders, Murli Krishna Pharma gathers valuable feedback and insights that drive continuous improvement and innovation.
Furthermore, the company upholds the highest ethical standards in all its operations, prioritizing transparency, integrity, and social responsibility. Murli Krishna Pharma is dedicated to serving the community and contributing to the betterment of society through its pharmaceutical offerings and initiatives.
